Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial Fibrillation.

Marinchak1, Kowey, Rials

  • 1Electrophysiology Section, Main Line Health, 100 Lancaster Ave., Wynnewood, PA 19096, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Megacolon: Acute, Toxic, and Chronic.

Current treatment options in gastroenterology·2000
Same author

Observation of atomic Wannier-Stark ladders in an accelerating optical potential.

Physical review letters·1996
Same author

Can a single-pulse standing wave induce chaos in atomic motion?

Physical review letters·1996
Same author

Atom optics realization of the quantum delta -kicked rotor.

Physical review letters·1995
Same author

Study of Quantum Dynamics in the Transition from Classical Stability to Chaos.

Physical review letters·1995
Same author

Observation of dynamical localization in atomic momentum transfer: A new testing ground for quantum chaos.

Physical review letters·1994
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Atrial fibrillation (AF) poses a significant challenge, with risks including stroke and death. While anticoagulation is key, nonpharmacologic therapies are being investigated to improve patient outcomes.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Clinical Electrophysiology

Background:

  • Atrial fibrillation (AF) is a growing global health concern, particularly with increasing elderly populations and longevity.
  • The arrhythmia presents with diverse clinical manifestations, ranging from asymptomatic to severely symptomatic and paroxysmal to permanent forms.
  • Major risks associated with AF include stroke and mortality, necessitating effective management strategies.

Purpose of the Study:

  • To review the current challenges in managing atrial fibrillation (AF).
  • To discuss the primary risks of AF, including stroke and death.
  • To evaluate the role of current pharmacologic and emerging nonpharmacologic therapies in AF management.

Main Methods:

  • Review of current clinical practices and therapeutic approaches for atrial fibrillation (AF).

Related Experiment Videos

  • Analysis of the efficacy of pharmacologic treatments, focusing on anticoagulation for stroke prevention.
  • Examination of ongoing basic and clinical research into nonpharmacologic interventions for AF.

    • Main Results:

    • Current therapies primarily focus on symptom management and stroke prevention through anticoagulation.
    • The benefit of AF prevention on overall survival has not yet been definitively established.
    • Nonpharmacologic therapies are under active investigation as potentially superior methods for improving patient outcomes.

    Conclusions:

    • Atrial fibrillation (AF) management is a critical challenge, especially in aging populations.
    • While anticoagulation is essential for preventing thromboembolic complications, its impact on survival is unproven.
    • Nonpharmacologic treatments represent a promising frontier for enhancing the care and outcomes of patients with atrial fibrillation.